miRNA Tools and Services Market is Becoming a Significant Focus of Discussion in Diagnostics and Biotech Industry: Forecast 2017-2023

miRNA Tools and Services Market was valued at $146 million in 2015 and is expected to garner $620 million by 2022, registering a CAGR of 23.4% during the forecast period 2016 - 2022. The market is expected to witness significant growth owing to the rise in incidence of cancer and cardiovascular diseases. Moreover, use of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth and the potential of miRNAs to act as candidates for diagnostic biomarkers are anticipated to further contribute to the demand for miRNA globally. However, the challenges related to quantification and the development of in-house miRNA research tools such as microarrays are expected to impede the market growth.

Increased funding by government and private organizations such as NIH is expected to drive the market growth. This is due to the large number of research projects undertaken to prove the therapeutic and diagnostic potential of miRNAs.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2103

MicroRNAs(miRNAs) are a class of non-coding RNAs that play a major role in regulating gene expressions. These molecules work at the post-transcription level and modify the expression of around 30% of all mammalian protein-encoding genes. Use of bioinformatics and technologically advanced systems (such as NGS) and rise in incidence of chronic disorders drive the market growth. In addition, the ability of miRNAs to act as diagnostic biomarkers and predictors of drug response are anticipated to drive the demand for miRNA. However, the challenges related to the quantification and the development of in-house miRNA research tools such as microarrays restrict the market growth.

The qRT-PCR technology segment is expected to maintain its dominant position throughout the analysis period due to the increase in incidence of chronic diseases such as cancer and cardiovascular disorders. The rise in demand for the identification of miRNA in different organisms and their associated role as a diagnostic biomarker for the disease also boost the market growth.

Research and academic institutes segment dominated the market with more than two-fifths of the total market in 2015. This is primarily attributed to the increase in research projects undertaken to test the ability of miRNA as candidates of disease biomarkers.

Key Findings of the Study:

• Research tools led the global miRNA tools and services market, and accounted for nearly four-fifths of the total market in 2015.
• Functional studies services segment is projected to grow at highest CAGR of 31.2% during the forecast period.
• CROs is the fastest growing segment and is expected to grow at a CAGR of 27.4% during the forecast period.
• qRT-PCR technology segment occupied nearly one-third of the market in 2015.
• In 2015 Japan was the major shareholder and accounted for almost one-third of the Asia-Pacific market.

Get More Informaion @ https://www.alliedmarketresearch.com/purchase-enquiry/2103

North America led the overall market in 2015 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased funding for miRNA research and increase in incidence of chronic disorders such as cancer. However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period owing to increase in investment by pharma and biotech companies in the emerging markets (such as India and China).

The major companies profiled in the report include QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., GeneCopoeia, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Merck & Co., Inc., and New England Biolabs.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. TOP PLAYER POSITIONING
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increasing incidence of cancer and cardiovascular disorders
3.4.1.2. Increased research funding for miRNA
3.4.2. Restraints
3.4.2.1. Development of in-house tools reduces commercial consumption
3.4.2.2. Challenges in quantification of miRNA
3.4.3. Opportunities
3.4.3.1. Application of miRNA technology
3.4.3.1.1. miRNA biomarkers
3.4.4. Impact analysis
3.5. CLINICAL TRIALS

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/mirna-tools-and-services-market.html

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

This release was published on openPR.